• WATSON PHARMACEUTICALS INC Cash Flow

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Net Income/Starting Line 141.03 M -445.00 M 138.23 M 150.02 M 202.86 M
    Operating Activities
    Depreciation, Depletion & Amortization 253.56 M 218.35 M 206.73 M 106.67 M 100.35 M
    Depreciation & Depletion 77.15 M 54.64 M 42.79 M 34.38 M 28.48 M
    Amortization of Intangible Assets 176.41 M 163.71 M 163.94 M 72.29 M 71.87 M
    Deferred Income Taxes and Investment Tax credity 39.54 M 58.09 M 13.89 M 11.56 M 10.77 M
    Deferred Income Taxes 39.54 M 58.09 M 13.89 M 11.56 M 10.77 M
    Income Tax Credit
    Other Cash Flow 56.59 M 606.42 M 76.13 M 73.86 M 10.42 M
    Funds from Operations 444.92 M 355.07 M 415.73 M 408.16 M 283.39 M
    Extraordinary Items & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Funds from/for Other Operating Activities -17.75 M 116.30 M -90.23 M -37.05 M -20.87 M
    Incline (Decline) in Receivables 120.58 M 66.17 M -82.37 M -40.28 M -34.24 M
    Incline (Decline) in Inventories -25.09 M -53.68 M 1.04 M 72.09 M -45.53 M
    Incline (Decline) in Accounts Payable -117.75 M 116.71 M 18.46 M -24.17 M 43.03 M
    Incline (Decline) in Income Taxes Payable 7.70 M -9.09 M -29.06 M -54.13 M 438,000.00
    Incline (Decline) in Other Accruals
    Incline (Decline) in Other Assets or Liabilties -3.18 M -3.81 M 1.70 M 9.44 M 15.43 M
    Net Cash Flow/Operating Activities 427.18 M 471.36 M 325.50 M 308.27 M 262.52 M
    Capital Expenditures (Additions to Fixed Assets)
    Additions to Other Assets 821,000.00 597,000.00 3.00 M 29.84 M 179.61 M
    Net Assets from Acquisitions 0.00 1.56 B 0.00 0.00 15.10 M
    Incline (Decline) in Inventories 8.45 M 18.84 M 26.08 M 216.52 M 0.00
    Decrease in Investments 4.11 M 158.18 M 220.08 M 72.36 M 42.77 M
    Disposal of Fixed Assets 14.38 M 21.56 M 30.48 M 16.37 M
    Other Uses - Investing -1.53 M -23.03 M -4.19 M -5.79 M -16.98 M
    Other Sources - Investing 1.53 M 23.03 M 4.19 M 5.79 M 16.98 M
    Net Cash Flow - Investing 64.29 M 1.42 B -116.36 M 206.93 M 269.95 M
    Proceeds from Stock Options 16.16 M 8.14 M 28.42 M 32.26 M 36.96 M
    Other Proceeds from Sale/Issues of Stock 0.00 0.00 0.00 0.00 0.00
    Com/Pfd Purchase, Retired, Converted, Redeemed 1.78 M 0.00 300.00 M 0.00 0.00
    Financing Activities
    Long Term Borrowings 0.00 650.00 M 0.00 0.00 560.62 M
    Incline or Decline in Short Term Borrowings 2.64 M 0.00 0.00 -152.98 M -265.95 M
    Reduction in Long Term Debt 329.53 M 0.00 0.00 0.00 0.00
    Cash Dividends Paid Total 0.00 0.00 0.00 0.00 0.00
    Common Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Preferred Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Other Sources - Financing 0.00 0.00 0.00 0.00 0.00
    Other Uses - Financing 0.00 -23.36 M -1.48 M -8,000.00 -1.01 M
    Net Cash Flow - Financing -312.50 M 634.77 M -273.06 M -120.73 M 330.63 M
    Effect of Exchange rate on Cash
    Changes in Cash and/or Liquid Items